07Nov 2023
Identification of novel diagnostic panel for mild cognitive impairment and Alzheimer’s disease

Identification of novel diagnostic panel for mild cognitive impairment and Alzheimer’s disease

A urine sample study unveiled promising diagnostic panels for AD and Mild Cognitive Impairment (MCI). They identified 33 significant differential proteins between AD and cognitively normal (CN) subjects and 15 proteins for MCI. These panels, constructed using machine learning techniques, demonstrated impressive accuracy in differentiating AD and MCI from CN. The procedure is convenient and could revolutionize early AD diagnosis, offering hope in the fight against this global burden.

  • #neurology

Like

Save

Share